Cannrx Technology
One Rockefeller Plaza, 11th Floor
New York
New York
10020
United States
Tel: 646-224-6966
Fax: 646-224-6965
Website: http://www.cannrx.com
Email: info@cannrx.com
About Cannrx Technology
CannRx Technology Inc. is a US-based corporation and a subsidiary of Izun Pharmaceuticals Corporation. CannRx was established to become a leader in the development of medical applications for the cannabis plant. CannRx differentiates itself from the complicated legal and social issues being debated on an almost daily basis with respect to cannabis usage. CannRx does not focus on the “medical marijuana” or “recreational marijuana” which are currently being sold and which suffer from the drawback of concerns relating to potency and purity. Instead it is the primary intent of CannRx to leverage off an established, patented technology platform that has been developed and applied to other botanical species, apply it to the cannabis plant and establish itself as a market leader in the development of medical applications. In addition, CannRx intends to further differentiate itself through development of (1) disease specific predictive models to aid in development of therapeutic applications and (2) rapid on-site testing devices.YEAR FOUNDED:
2013
LEADERSHIP:
CEO: Jack V. Talley
CFO: Leslie Kraus
3 articles about Cannrx Technology
-
CannRx Chief R&D Officer to Present Poster at MJBizCon INT'L 2019
9/4/2019
CannRx, a company developing proprietary, scientifically based medical and recreational products, today announced that Dr. Shimon Lecht, the Company's Chief R&D Officer, will present a poster at this year's MJBizCon INT'L conference in Toronto, Canada
-
New Data Shows CannRx's CannTrap Technology Optimizes Cannabis Product Effects
8/14/2019
CannRx Applies Proven Pharmaceutical Methods to New Product Development Technologies in Cannabis Industry
-
Cannrx Technology And iCAN: Israel-Cannabis Announce Formation Of A Joint Venture To Market The First Advanced Sleep Cannabis Formulation: Ican.Sleep
3/20/2017